Go Back

Company or ticker...

Revolution Medicines

Revolution Medicines develops targeted oncology drugs, especially for RAS-driven cancers.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

RVMD

43.3B

0.0

n/a

149.28%

Key Facts

M. Cap

PS

PE

YTD

43.3B

0.0

n/a

149.28%

10MA

20MA

50MA

200MA

$RVMD

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now